Dementia, Alzheimer's type

Citations 1-10 of 51 total displayed.

Prognosis
Cognitive decline fastest in people with Alzheimer’s disease compared with other dementias

Rob Butler
Evid. Based Ment. Health 2009; 12: 105. [Extract] [Full text] [PDF] [Request Permissions] [ web only appendices ]  

Therapeutics
Ginkgo biloba does not reduce incidence of dementia in elderly people

Robert Hoerr
Evid. Based Ment. Health 2009; 12: 85. [Extract] [Full text] [PDF] [Request Permissions] [ Web only appendix ]  

Therapeutics
High dose vitamin B supplementation does not slow cognitive decline in mild to moderate Alzheimer’s disease

Peter Connelly
Evid. Based Ment. Health 2009; 12: 86. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Physical activity improves cognitive function in people with memory impairment

R Stewart
Evid. Based Ment. Health 2009; 12: 57. [Extract] [Full text] [PDF] [Request Permissions] [ Web only appendix ]  

Therapeutics
Rivastigmine three times daily improves cognition and response in Alzheimer’s disease

Martin R Farlow
Evid. Based Ment. Health 2007; 10: 116. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: pharmacotherapy provides minimal improvements in the neuropsychiatric symptoms of dementia

Benoit H Mulsant
Evid. Based Ment. Health 2005; 8: 83. [Extract] [Full text] [PDF] [Request Permissions] [ Web-only table ]  

Therapeutics
Regular exercise and behavioural management by caregivers improves physical and mental health of people with Alzheimer’s disease

Henry Brodaty
Evid. Based Ment. Health 2004; 7: 43. [Extract] [Full text] [PDF] [Request Permissions] [ Web extra ]  

Therapeutics
Rofecoxib or naproxen do not slow progression of mild to moderate Alzheimer’s disease

Robin Jacoby
Evid. Based Ment. Health 2003; 6: 110. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer’s disease

Debomoy K Lahiri, Martin R Farlow
Evid. Based Ment. Health 2003; 6: 94. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: selegiline leads to a small short term improvement in cognition and activities of daily living in Alzheimer's disease

Jay S Luxenberg
Evid. Based Ment. Health 2002; 5: 88. [Extract] [Full text] [PDF] [Request Permissions]